When scent makes up for taste
GLP-1 drugs such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro commonly cause nausea and gastrointestinal problems. Researchers are also studying other effects, some unexpected, such as reduced cravings for alcohol, fewer urges to gamble or impulse-shop, and changes to smell and taste.
Paule Joseph, co-director of the National Smell and Taste Center at the US National Institutes of Health, said that as GLP-1 drugs reshape appetite, they also affect the tissue of the olfactory bulb, which processes odor. She stressed, however, that it is too early to predict how, or even whether, this affects the way people perceive smells.
GLP-1 drugs having a chemosensory effect is not a far-fetched idea.
All four companies that have explored the link, as well as four scientists interviewed by Reuters, said more research is needed before firm conclusions can be drawn.

















